How High Could IBIT Go?
Recently, a surprising number of billionaire hedge fund managers have…
Buy
64
LBRDA Quote, Financials, Valuation and Earnings
Last price:
$84.82
Seasonality move
:
-0.06%
Day range:
$83.09 - $85.00
52-week range:
$47.17 - $100.44
Dividend yield:
0%
P/E ratio:
13.99x
P/S ratio:
11.97x
P/B ratio:
1.24x
Volume:
65.4K
Avg. volume:
100.7K
1-year change:
48.81%
Market cap:
$12.2B
Revenue:
$1B
EPS (TTM):
$6.08
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $51M | $988M | $975M | $981M | $1B | |
| Revenue Growth (YoY) | 240% | 1837.26% | -1.32% | 0.62% | 3.57% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $76M | $442M | $432M | $433M | $460M | |
| Other Inc / (Exp) | $449M | $1.1B | $1.6B | $1B | $1.2B | |
| Operating Expenses | $111M | $991M | $947M | $908M | $924M | |
| Operating Income | -$60M | -$3M | $28M | $73M | $92M | |
| Net Interest Expenses | $28M | $117M | $133M | $206M | $194M | |
| EBT. Incl. Unusual Items | $361M | $950M | $1.5B | $888M | $1.1B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$37M | $218M | $277M | $200M | $213M | |
| Net Income to Company | $398M | $732M | $1.3B | $688M | $869M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $398M | $732M | $1.3B | $688M | $869M | |
| Basic EPS (Cont. Ops) | $2.18 | $3.97 | $8.01 | $4.71 | $6.08 | |
| Diluted EPS (Cont. Ops) | $2.17 | $3.93 | $7.96 | $4.71 | $6.08 | |
| Weighted Average Basic Share | $182M | $185M | $157M | $146M | $143M | |
| Weighted Average Diluted Share | $183.2M | $186M | $158M | $147M | $143M | |
| EBITDA | $404M | $1.3B | $1.9B | $1.3B | $1.5B | |
| EBIT | $389M | $1.1B | $1.7B | $1.1B | $1.3B | |
| Revenue (Reported) | $51M | $988M | $975M | $981M | $1B | |
| Operating Income (Reported) | -$60M | -$3M | $28M | $73M | $92M | |
| Operating Income (Adjusted) | $389M | $1.1B | $1.7B | $1.1B | $1.3B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $38.6M | $249M | $250M | $250M | $263M | |
| Revenue Growth (YoY) | 844.71% | 545.7% | 0.4% | -- | 5.2% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $38.7M | $117M | $115M | $111M | $131M | |
| Other Inc / (Exp) | $220.3M | $525M | $269M | $304M | $371M | |
| Operating Expenses | $65.1M | $260M | $245M | $237M | $250M | |
| Operating Income | -$26.6M | -$11M | $5M | $13M | $13M | |
| Net Interest Expenses | $13.3M | $27M | $42M | $55M | $45M | |
| EBT. Incl. Unusual Items | $180.5M | $487M | $232M | $262M | $339M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$84.2M | $100M | $54M | $57M | $48M | |
| Net Income to Company | $264.7M | $387M | $178M | $205M | $291M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $264.7M | $387M | $178M | $205M | $291M | |
| Basic EPS (Cont. Ops) | $1.45 | $2.13 | $1.27 | $1.40 | $2.04 | |
| Diluted EPS (Cont. Ops) | $1.44 | $2.11 | $1.26 | $1.40 | $2.04 | |
| Weighted Average Basic Share | $182.8M | $176M | $148M | $146M | $143M | |
| Weighted Average Diluted Share | $184.8M | $176M | $149M | $147M | $143M | |
| EBITDA | $207.7M | $582M | $341M | $378M | $434M | |
| EBIT | $193.8M | $514M | $274M | $317M | $384M | |
| Revenue (Reported) | $38.6M | $249M | $250M | $250M | $263M | |
| Operating Income (Reported) | -$26.6M | -$11M | $5M | $13M | $13M | |
| Operating Income (Adjusted) | $193.8M | $514M | $274M | $317M | $384M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $51M | $988M | $975M | $981M | $1B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $76M | $442M | $432M | $433M | $460M | |
| Other Inc / (Exp) | $449M | $1.1B | $1.6B | $1B | $1.2B | |
| Operating Expenses | $111M | $991M | $947M | $908M | $924M | |
| Operating Income | -$60M | -$3M | $28M | $73M | $92M | |
| Net Interest Expenses | $28M | $117M | $133M | $206M | $194M | |
| EBT. Incl. Unusual Items | $361M | $950M | $1.5B | $888M | $1.1B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$37M | $218M | $277M | $200M | $213M | |
| Net Income to Company | $398M | $732M | $1.3B | $688M | $869M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $398M | $732M | $1.3B | $688M | $869M | |
| Basic EPS (Cont. Ops) | $2.19 | $4.01 | $8.02 | $4.71 | $6.08 | |
| Diluted EPS (Cont. Ops) | $2.17 | $3.97 | $7.95 | $4.68 | $6.08 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $404M | $1.3B | $1.9B | $1.3B | $1.5B | |
| EBIT | $389M | $1.1B | $1.7B | $1.1B | $1.3B | |
| Revenue (Reported) | $51M | $988M | $975M | $981M | $1B | |
| Operating Income (Reported) | -$60M | -$3M | $28M | $73M | $92M | |
| Operating Income (Adjusted) | $389M | $1.1B | $1.7B | $1.1B | $1.3B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $988M | $975M | $981M | $1B | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $442M | $432M | $433M | $460M | -- | |
| Other Inc / (Exp) | $1.1B | $1.6B | $1B | $1.2B | -- | |
| Operating Expenses | $991M | $947M | $908M | $924M | -- | |
| Operating Income | -$3M | $28M | $73M | $92M | -- | |
| Net Interest Expenses | $117M | $133M | $206M | $194M | -- | |
| EBT. Incl. Unusual Items | $950M | $1.5B | $888M | $1.1B | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $218M | $277M | $200M | $213M | -- | |
| Net Income to Company | $732M | $1.3B | $688M | $869M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $732M | $1.3B | $688M | $869M | -- | |
| Basic EPS (Cont. Ops) | $4.01 | $8.02 | $4.71 | $6.08 | -- | |
| Diluted EPS (Cont. Ops) | $3.97 | $7.95 | $4.68 | $6.08 | -- | |
| Weighted Average Basic Share | $739M | $628M | $584M | $572M | -- | |
| Weighted Average Diluted Share | $745M | $634M | $588M | $572M | -- | |
| EBITDA | $1.3B | $1.9B | $1.3B | $1.5B | -- | |
| EBIT | $1.1B | $1.7B | $1.1B | $1.3B | -- | |
| Revenue (Reported) | $988M | $975M | $981M | $1B | -- | |
| Operating Income (Reported) | -$3M | $28M | $73M | $92M | -- | |
| Operating Income (Adjusted) | $1.1B | $1.7B | $1.1B | $1.3B | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $1.4B | $191M | $375M | $158M | $163M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $349M | $206M | $201M | $178M | $195M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $79M | $62M | $84M | $94M | $65M | |
| Total Current Assets | $1.8B | $459M | $660M | $430M | $423M | |
| Property Plant And Equipment | $1.1B | $1B | $1B | $1.1B | $1.2B | |
| Long-Term Investments | $16.2B | $13.3B | $11.4B | $12.1B | $13.1B | |
| Goodwill | $746M | $762M | $755M | $755M | $755M | |
| Other Intangibles | $1.3B | $1.2B | $1.1B | $1.1B | $1B | |
| Other Long-Term Assets | $151M | $296M | $180M | $236M | $300M | |
| Total Assets | $21.4B | $17B | $15.1B | $15.6B | $16.7B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | $113M | $106M | $137M | $59M | $64M | |
| Total Current Liabilities | $612M | $582M | $1.7B | $178M | $200M | |
| Long-Term Debt | $4.8B | $3.7B | $2.4B | $3.7B | $3.8B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $7.9B | $6.8B | $6.6B | $6.6B | $6.9B | |
| Common Stock | $2M | $1M | $1M | $1M | $1M | |
| Other Common Equity Adj | $15M | $14M | $9M | $52M | $73M | |
| Common Equity | $13.5B | $10.1B | $8.5B | $9B | $9.8B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $12M | $12M | $18M | $20M | $15M | |
| Total Equity | $13.5B | $10.1B | $8.5B | $9B | $9.8B | |
| Total Liabilities and Equity | $21.4B | $17B | $15.1B | $15.6B | $16.7B | |
| Cash and Short Terms | $1.4B | $191M | $375M | $158M | $163M | |
| Total Debt | $4.8B | $3.8B | $3.8B | $3.7B | $3.8B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $1.4B | $191M | $375M | $158M | $163M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $349M | $206M | $201M | $178M | $195M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $79M | $62M | $84M | $94M | $65M | |
| Total Current Assets | $1.8B | $459M | $660M | $430M | $423M | |
| Property Plant And Equipment | $1.1B | $1B | $1B | $1.1B | $1.2B | |
| Long-Term Investments | $16.2B | $13.3B | $11.4B | $12.1B | $13.1B | |
| Goodwill | $746M | $762M | $755M | $755M | $755M | |
| Other Intangibles | $1.3B | $1.2B | $1.1B | $1.1B | $1B | |
| Other Long-Term Assets | $151M | $296M | $180M | $236M | $300M | |
| Total Assets | $21.4B | $17B | $15.1B | $15.6B | $16.7B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | $113M | $106M | $137M | $59M | $64M | |
| Total Current Liabilities | $612M | $582M | $1.7B | $178M | $200M | |
| Long-Term Debt | $4.8B | $3.7B | $2.4B | $3.7B | $3.8B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $7.9B | $6.8B | $6.6B | $6.6B | $6.9B | |
| Common Stock | $2M | $1M | $1M | $1M | $1M | |
| Other Common Equity Adj | $15M | $14M | $9M | $52M | $73M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $12M | $12M | $18M | $20M | $15M | |
| Total Equity | $13.5B | $10.1B | $8.5B | $9B | $9.8B | |
| Total Liabilities and Equity | $21.4B | $17B | $15.1B | $15.6B | $16.7B | |
| Cash and Short Terms | $1.4B | $191M | $375M | $158M | $163M | |
| Total Debt | $4.8B | $3.8B | $3.8B | $3.7B | $3.8B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $398M | $732M | $1.3B | $688M | $869M | |
| Depreciation & Amoritzation | $15M | $267M | $262M | $230M | $207M | |
| Stock-Based Compensation | $9M | $41M | $37M | $34M | $28M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$96M | $3M | -$56M | $16M | $104M | |
| Capital Expenditures | $2M | $134M | $181M | $222M | $247M | |
| Cash Acquisitions | $577M | $4.2B | $3.2B | $394M | $335M | |
| Cash From Investing | $575M | $4.1B | $3B | $150M | $130M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $2.8B | $1.5B | $325M | $1.5B | $1.1B | |
| Long-Term Debt Repaid | -$1.3B | -$2.5B | -$231M | -$1.6B | -$1.2B | |
| Repurchase of Common Stock | -$597M | -$4.3B | -$2.9B | -$227M | -$89M | |
| Other Financing Activities | -$23M | -$11M | -$9M | -$48M | -$30M | |
| Cash From Financing | $904M | -$5.3B | -$2.8B | -$390M | -$181M | |
| Beginning Cash (CF) | $50M | $1.4B | $206M | $400M | $176M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $1.4B | -$1.2B | $194M | -$224M | $53M | |
| Ending Cash (CF) | $1.4B | $206M | $400M | $176M | $229M | |
| Levered Free Cash Flow | -$98M | -$131M | -$237M | -$206M | -$143M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $264.7M | $387M | $178M | $205M | $291M | |
| Depreciation & Amoritzation | $14M | $68M | $67M | $61M | $50M | |
| Stock-Based Compensation | $3.3M | $10M | $9M | $9M | $6M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$59.2M | -$133M | $4M | $62M | $1M | |
| Capital Expenditures | $2M | $43M | $49M | $73M | $64M | |
| Cash Acquisitions | $591.9M | $1.6B | $432M | $352M | $109M | |
| Cash From Investing | $590M | $1.5B | $410M | $279M | $61M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $2.1B | $400M | $25M | -- | $25M | |
| Long-Term Debt Repaid | -$1.3B | -$628M | -$28M | -$69M | -$3M | |
| Repurchase of Common Stock | -$311.3M | -$1.4B | -$241M | -$187M | -- | |
| Other Financing Activities | -$11M | -$10M | -$4M | -$19M | -$29M | |
| Cash From Financing | $501.7M | -$1.6B | -$248M | -$275M | -$7M | |
| Beginning Cash (CF) | $400.3M | $445M | $234M | $110M | $174M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $1B | -$239M | $166M | $66M | $55M | |
| Ending Cash (CF) | $1.4B | $206M | $400M | $176M | $229M | |
| Levered Free Cash Flow | -$61.1M | -$176M | -$45M | -$11M | -$63M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $398M | $732M | $1.3B | $688M | $869M | |
| Depreciation & Amoritzation | $15M | $267M | $262M | $230M | $207M | |
| Stock-Based Compensation | $9M | $41M | $37M | $34M | $28M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$96M | $3M | -$56M | $16M | $104M | |
| Capital Expenditures | $2M | $134M | $181M | $222M | $247M | |
| Cash Acquisitions | $577M | $4.2B | $3.2B | $394M | $335M | |
| Cash From Investing | $575M | $4.1B | $3B | $150M | $130M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $1.5B | $325M | $1.5B | $1.1B | |
| Long-Term Debt Repaid | -$1.3B | -$2.5B | -$231M | -$1.6B | -$1.2B | |
| Repurchase of Common Stock | -$597M | -$4.3B | -$2.9B | -$227M | -$89M | |
| Other Financing Activities | -$23M | -$11M | -$9M | -$48M | -$30M | |
| Cash From Financing | $904M | -$5.3B | -$2.8B | -$390M | -$181M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $1.4B | -$1.2B | $194M | -$224M | $53M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$98M | -$131M | -$237M | -$206M | -$143M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $732M | $1.3B | $688M | $869M | -- | |
| Depreciation & Amoritzation | $267M | $262M | $230M | $207M | -- | |
| Stock-Based Compensation | $41M | $37M | $34M | $28M | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $3M | -$56M | $16M | $104M | -- | |
| Capital Expenditures | $134M | $181M | $222M | $247M | -- | |
| Cash Acquisitions | $4.2B | $3.2B | $394M | $335M | -- | |
| Cash From Investing | $4.1B | $3B | $150M | $130M | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $1.5B | $325M | $1.5B | $1.1B | -- | |
| Long-Term Debt Repaid | -$2.5B | -$231M | -$1.6B | -$1.2B | -- | |
| Repurchase of Common Stock | -$4.3B | -$2.9B | -$227M | -$89M | -- | |
| Other Financing Activities | -$11M | -$9M | -$48M | -$30M | -- | |
| Cash From Financing | -$5.3B | -$2.8B | -$390M | -$181M | -- | |
| Beginning Cash (CF) | $3.3B | $1.1B | $807M | $543M | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$1.2B | $194M | -$224M | $53M | -- | |
| Ending Cash (CF) | $2.1B | $1.3B | $583M | $596M | -- | |
| Levered Free Cash Flow | -$131M | -$237M | -$206M | -$143M | -- | |
Get LBRDA Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
LBRDA
Sector
P/E ratio
13.99x
17.30x
PEG ratio
0.47x
0.01x
P/B ratio
1.24x
1.40x
Price / LTM sales
11.97x
0.90x
Growth Metrics
LBRDA
Sector
Revenue growth
5.2%
1.18%
Earnings growth
45.71%
7.04%
Revenue (5-year growth)
132.36%
1.7%
Earnings forecast
--
$0.04
Profitability
LBRDA
Sector
Profitability FY 2025
--
$326.3M
Return on invested capital
6.65%
0.29%
Return on assets
5.41%
-0.01%
Return on equity
9.27%
1.73%
Earnings Date
Last Earnings Date
Feb
27
Next Earnings Date
May
8
Estimated Next Earnings Date
May
29
Balance Sheet
LBRDA
Sector
Total cash
$163M
$104.5M
Short term investments
--
$36.4M
Total assets
$16.7B
$915.5M
Long term debt
$3.8B
$52.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Raymond James Stock a Buy, Sell or Hold?
Raymond James Financial (NYSE:RJF) is one of America’s large financial…
Is JHX Stock a Buy Sell or Hold?
James Hardie Industries (NYSE:JHX) is a manufacturer of outside building…
Stock Ideas
Buy
56
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
41
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Buy
80
CORT alert for Apr 1
Corcept Therapeutics [CORT] is up 109.21% over the past day.
Sell
40
RGC alert for Mar 31
Regencell Bioscience Holdings [RGC] is up 26.1% over the past day.
Buy
74
COOP alert for Apr 1
Mr. Cooper Group [COOP] is up 14.4% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
